Automated Microbial Identification Market

Top 10 Companies in the Global Automated Microbial Identification Market (2025-2035): Expert View by Spherical Insights

RELEASE DATE: Mar 2026 Author: Spherical Insights
Global Automated Microbial Identification Market Size is projected to grow from USD 525.6 Million in 2024 to USD 1,050.75 Million by 2035, at a CAGR of 6.5% during the forecast period 2025–2035

Request Free Sample Speak to Analyst

According to a research report published by Spherical Insights & Consulting, the Global Automated Microbial Identification Market Size is projected to grow from USD 525.6 Million in 2024 to USD 1,050. 75 Million by 2035, at a CAGR of 6.5% during the forecast period 2025–2035. Global market expansion is fuelled by growing demand in several industries for rapid and accurate diagnosis of microbial infections and technological developments.

 

Introduction

The high prevalence of infectious diseases needs doctors to diagnose and treat patients effectively while people understand rapid microbiology testing provides benefits which create demand for automated microbial identification systems. Automated microbial identification systems deliver bacteria identification results which are both faster and more precise than traditional methods that require multiple days to identify infectious bacteria through culture-based procedures. The development of microbial identification technologies needs artificial intelligence and molecular techniques because these technologies boost identification accuracy as well as operational efficiency.

Automated systems or tools can identify microorganisms which include bacteria and yeast and fungi based on their biochemical and morphological and genotypic characteristics. The systems employ multiple technologies which include mass spectrometry and PCR and flow cytometry to examine microorganisms and produce accurate identification results through genetic and metabolic analysis. The automated microbial identification system serves three main purposes which include its use in manufacturing operations and clinical environments and environmental research activities

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

   Automated Microbial Identification Market Size & Statistics

  • The Market Size for Automated Microbial Identification Was Estimated to be worth USD 525.6 Million in 2024.
  • The Market Size is Going to Expand at a CAGR of 6.5% between 2025 and 2035.
  • The Global Automated Microbial Identification Market Size is anticipated to reach USD 1,050. 75 Million by 2035.
  • North America is estimated to dominate the market during the forecast period in the Automated Microbial Identification Market.
  • Asia-Pacific is projected to grow the fastest during the forecast period in the Automated Microbial Identification Market.

Automated Microbial Identification Market

Global Automated Microbial Identification Market Size, Share, By Product Type (Instruments, Consumables, and Services), By Technology (PCR-Based Systems, Mass Spectrometry System, and Flow Cytometry Systems), By End User (Clinical Laboratories, Hospitals, Research and Academic Institutes, Biotechnology Companies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.

 

Regional growth and demand

 

North America is expected to dominate the market during the forecast period in the automated microbial identification market.

North America held the majority of the market share by revenue for the automated microbial identification market. The largest shareholder in the global automated microbial identification market is North America, which is anticipated to grow significantly over the course of the projected period. The use of cutting-edge tools and technology for microbial identification is made possible by the existence of a well-established healthcare infrastructure. Innovation and the commercialization of new microbial identification goods and services are supported by increased financing for research and development in the biotechnology and life science sectors. Additionally, there is growing concern about food safety and environmental monitoring, necessitating the employment of microbial identification methods to ensure the quality and safety of food products and water sources.

 

Asia-Pacific is projected to grow the fastest during the forecast period in the automated microbial identification market.

The current rapid growth of the industry results from three main factors, which include extensive spending on healthcare facilities, the increasing incidence of infectious diseases, and the implementation of more stringent food safety and pharmaceutical testing standards that China and India have established. North America holds the position of largest market because its diagnostic systems use advanced technology, but Asia-Pacific shows rapid progress toward becoming a competitor because it upgrades its laboratory operations with advanced MALDI-TOF mass spectrometry systems and automated artificial intelligence solutions

 

Top 10 Trends in the Automated Microbial Identification Market

  • Integration of AI and Machine Learning
  • Quick Acceptance of MALDI-TOF MS
  • Transition to Molecular and Genotypic Methods
  • Decentralized Point-of-Care Testing (POCT)
  • End-to-End Automated Workflows
  • Real-Time Data Monitoring
  • Antimicrobial Resistance (AMR) Surveillance
  • Industrial Quality Control
  • Collaborations and Partnerships
  • Emerging Markets

 

  1. Integration of AI and Machine Learning

The combination of artificial intelligence with machine learning methods enables scientists to analyse complex spectral and genetic data which leads to identification accuracy beyond 96 percent and requires only fractional second analysis time.

 

       2.Quick Acceptance of MALDI-TOF MS

The gold standard for Time-of-Flight Mass Spectrometry (MALDI-TOF MS) testing has emerged from its ability to perform tests with high accuracy and rapid results while testing a progressively increasing number of organisms.

 

       3.Transition to Molecular and Genotypic Methods

Genotypic testing methods, which include PCR and Next-Generation Sequencing (NGS), have surpassed traditional culture-based testing methods because they provide better strain-level identification accuracy.

 

       4.Decentralized Point-of-Care Testing (POCT)

The development of portable automated testing equipment enables emergency rooms and rural clinics and field operations to perform rapid microbiological identification through decentralized Point-of-Care Testing (POCT).

 

       5.End-to-End Automated Workflows

Laboratories implement complete "robotic track" systems which handle all testing processes from susceptibility testing through detection to sample preparation and incubation.

 

Empower your strategic planning

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the anti-venom market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 10 Companies Leading the Automated Microbial Identification Market

  1. BioMerieux SA
  2. Becton, Dickinson (BD)
  3. Thermo Fisher Scientific
  4. Danaher (Beckman Coulter)
  5. Bruker Corporation
  6. QIAGEN N.V.
  7. Charles River Labs
  8. Merck KGaA
  9. Shimadzu
  10. Roche Diagnostics

 

  1. BioMerieux SA

Headquarters: Marcy-IEtoile, France

Founded in 1897, it is expected to generate $20.18 billion in revenue in 2024. BD Phoenix, BD Bactec, BD Bruker MALDI Biotyper are among its key product lines. About 30 manufacturing and distribution centres are mainly found in the U.S. alone.

 

        2.Becton, Dickinson (BD)

Headquarters: Franklin Lakes, NJ, USA

It is an establishment of 1897 with revenue for the year 2024 estimated to be of $ 20.18 billion. Its core product range consists of BD phoenix, BD Bactec, BD Bruker MALDI Biotyper. The majority of manufacturing and distribution (around 30) sites are in U.S. alone.

 

        3.Thermo Fisher Scientific

Headquarters: Waltham, MA, USA

It was formed in 2006, and Its 2024 gross revenue was around $42.88 billion. It specialises in applied biosystems microSEQ, Sensititre, MALDI-TOF. It has 400 active sites with operations in more than 25 countries globally. It is one of the significant investors in Indian and Sweden markets.

 

        4.Danaher (Beckman Coulter)

Headquarters: Brea, CA, USA

It is an establishment of 1935 and had group revenue of $23.90 billion in 2024 through its global presence. Moreover. its product line consists of microscan walkaway, Genexpert. In the year, 2024, it completed the installation of over 13,000 GeneXpert systems, along with introduction of two new centres of innovation in diagnostics for transformation of precision medicine development. Danaher's installed base of equipment in over 30,000 hospitals across 120 countries presents the possibility of accelerating the commercialization of patient-specific care.

 

      5.Bruker Corporation

Headquarters: Billerica, MA, USA

It was formed in 1960, and Its 2024 gross revenue was around $3.20 billion. It specialises in MALDI Biotyper (Sirius/LT), MBT Sepsityer. It is active in more than 90 locations. It is prominent leader in MALDI-TOF technology and to enhance its molecular footprint it acquired ELITech group in 2024.

 

Are you ready to discover more about the Automated Microbial Identification Market?

The report provides an in-depth analysis of the leading companies operating in the global automated microbial identification market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardised format that includes:

 

Company Profile

  1. BioMerieux SA
  • Business Overview
  • Company Snapshot
  • Products Overview
  • Company Market Share Analysis
  • Company Coverage Portfolio
  • Financial Analysis
  • Recent Developments
  • Merger and Acquisitions
  • SWOT Analysis

 

Conclusion

The global automated microbial identification market size is expected to grow at a compound annual growth rate (CAGR) of 6.5%, from USD 525.6 million in 2024 to USD 1,050. 75 million by 2035. Global market expansion is fuelled by growing demand in several industries for rapid and accurate diagnosis of microbial infections and technological developments. North America is expected to dominate the market during the forecast period in the automated microbial identification market due to its high advance technological and healthcare infrastructure. Asia-Pacific is projected to grow the fastest during the forecast period in the automated microbial identification market due to its extensive spending on healthcare facilities, the increasing incidence of infectious diseases, and the implementation of more stringent food safety and pharmaceutical testing standards that China and India have established.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies